Investors are re-evaluating large pharmaceutical companies due to innovations in GLP-1, AI-driven drug discovery, and changing healthcare consumption patterns, according to VanEck. (Read More)
from Blockchain News https://ift.tt/BowJH1D
Investors Reassess Large Pharmaceutical Firms Amid Technological Shifts
![Investors Reassess Large Pharmaceutical Firms Amid Technological Shifts]()
Reviewed by CRYPTO TALK
on
December 24, 2025
Rating:
No comments: